Table 2.
Outcome
|
Aspirin group (n = 30)
|
No aspirin group (n = 30)
|
Relative risk (95%CI)
|
P value
|
Primary outcome, n (%) | 2 (6.7) | 5 (16.7) | 0.40 (0.12-1.31) | |
Recurrent stroke, n (%) | 1 (3.3) | 3 (10) | 0.33 (0.04-2.76) | 0.31 |
Myocardial infarction, n (%) | 1 (3.3) | 1 (3.3) | 1.00 (0.07-14.42) | 1.00 |
Vascular death, n (%) | 1 (3.3) | 2 (6.7) | 0.50 (0.05-4.79) | 0.55 |
95%CI: 95% confidence interval.